Human Chorionic Gonadotropin (HCG) Market
- 2026 年市場規模
- USD 2.96 Bn
- 2033 年預估規模
- USD 3.12 Bn
- 年複合成長率 CAGR
- 3.68%
以上數字由 Coherent Market Insights 於本報告中提出，量子訊息原樣引用。
授權報價
| Single User Price | $4,500 USD |
| Enterprise License | $10,000 USD |
完整報告名稱與涵蓋範圍
Human Chorionic Gonadotropin (HCG) Market, By Product Type (Human Chorionic Gonadotropin and Recombinant Human Chorionic Gonadotropin), By Therapeutic Application (Male Hypogonadism, Female Infertility Treatment, Oligospermic Treatment, Cryptorchidism Treatment, Chronic Pain and Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Geography (North America, Latin America, Europe, Asia-Pacific, Middle East, and Africa)
報告摘要
Human chorionic gonadotropin (HCG) is a hormone secreted by the placenta after implantation of a fertilized zygote in the uterus. The hormone also supports normal development of an egg and helps in the stimulation of egg release from the ovary. HCG is mainly used to induce ovulation in the women under infertility treatment. It is also used among males, mostly to increase the sperm count and in young boys due to pituitary gland disorders and other diseases, owing to which the testicles of the young males do not drop down naturally into the scrotum. The HCG is usually administered as an injection under the skin into a muscle. The HCG can also be administered at home under the advice of a gynecologist or a pharmacist. The HCG levels can be determined with the help of urine or blood test. Result of specific test helps in determining accurate measurement of the levels. These tests are mostly used to identify and confirm pregnancy or as a screening test to determine birth defects. The hormone stimulates the corpus luteum to produce progesterone to maintain the pregnancy.
Market Dynamics
The increasing adoption of inorganic strategies such as partnerships and acquisitions by the key players in the market is expected to drive the market growth over the forecast period. For instance, in January 2021, Merck & Co., Inc., a science and technology company announced a multi-year partnership with Royal Philips, which is a health technology company, to develop clinical-grade digital solutions for highly personalized fertility treatment.
Key features of the study
• This report provides an in-depth analysis of the global human chorionic gonadotropin (HCG) market, and provides market size (USD Bn) and compound annual growth rate (CAGR%) for the forecast period (2026-2033), considering 2025 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
• It profiles key players in the global human chorionic gonadotropin (HCG) market based on the following parameters – Company Highlights, Products Portfolio, Key Highlights, Financial Performance, Strategies.
• Key companies covered as a part of this study includes Merck & Co., Inc., Ferring B.V., Fresenius SE & Co.KGaA, Lupin, Sun Pharmaceutical Industries Ltd, Lee BioSolutions, Serum Institute of India Pvt. Ltd., Scripps Laboratories, Sanzyme Biologics Pvt. Ltd., VHB Medi Sciences Limited, Bharat Serums And Vaccines Limited (BSV), Zydus Lifesciences Ltd, Corona Remedies Pvt. Ltd.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• The global human chorionic gonadotropin (HCG) market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global human chorionic gonadotropin hormone (HCG) market.
Market Segmentation
• By Product Type
o Human Chorionic Gonadotropin
o Recombinant Human Chorionic Gonadotropin
• By Therapeutic Application
o Male Hypogonadism
o Female Infertility Treatment
o Oligospermic Treatment
o Cryptorchidism Treatment
o Chronic Pain
o Others
• By Distribution Channel
o Hospital Pharmacies
o Retail Pharmacies
o Online Pharmacies
• By Regional Insights
o North America
U.S.
Canada
o Latin America
Brazil
Argentina
Mexico
Rest of Latin America
o Europe
Germany
U.K.
Spain
France
Italy
Russia
Rest of Europe
o Asia Pacific
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
o Middle East
GCC Countries
Israel
Rest of Middle East
o Africa
South Africa
North Africa
Central Africa
• Key Players Insights
o Merck & Co., Inc.
o Ferring B.V.
o Fresenius SE & Co.KGaA,
o Lupin
o Sun Pharmaceutical Industries Ltd.
o Lee BioSolutions
o Serum Institute of India Pvt. Ltd.
o Scripps Laboratories
o Sanzyme Biologics Pvt. Ltd.
o VHB Medi Sciences Limited Bharat Serums
o Vaccines Limited (BSV)
o Zydus Lifesciences Ltd
o Corona Remedies Pvt. Ltd.
目錄 Table of Contents
Table of Contents
1. Research Objectives and Assumptions
o Research Objectives
o Assumptions
o Abbreviations
2. Market Purview
o Report Description
Market Definition and Scope
o Executive Summary
Market Snippet, By Product Type
Market Snippet, By Therapeutic Application
Market Snippet, By Distribution Channel
Market Snippet, By Region
o Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
o Market Dynamics
Drivers
Restraints
PEST Analysis
PORTER’s Five Forces Analysis
Market Opportunities
Regulatory Scenario
Key Developments
Industry Trend
4. Global Human Chorionic Gonadotropin (HCG) Market, By Product Type, 2026-2033, (USD Bn)
o Introduction
Market Share Analysis, 2025, 2028, and 2033 (%)
Y-o-Y Growth Analysis, 2021 - 2033
Segment Trends
o Human Chorionic Gonadotropin
Market Share Analysis, 2025, 2028, and 2033 (%)
Y-o-Y Growth Analysis, 2021 – 2033
Segment Trends
o Recombinant Human Chorionic Gonadotropin
Market Share Analysis, 2025, 2028, and 2033 (%)
Y-o-Y Growth Analysis, 2021 – 2033
Segment Trends
5. Global Human Chorionic Gonadotropin (HCG) Market, By Therapeutic Application, 2026-2033, (USD Bn)
o Introduction
Market Share Analysis, 2025, 2028, and 2033 (%)
Y-o-Y Growth Analysis, 2021 - 2033
Segment Trends
o Male Hypogonadism
Market Share Analysis, 2025, 2028, and 2033 (%)
Y-o-Y Growth Analysis, 2021 – 2033
Segment Trends
o Female Infertility Treatment
Market Share Analysis, 2025, 2028, and 2033 (%)
Y-o-Y Growth Analysis, 2021 – 2033
Segment Trends
o Oligospermic Treatment
Market Share Analysis, 2025, 2028, and 2033 (%)
Y-o-Y Growth Analysis, 2021 – 2033
Segment Trends
o Cryptorchidism Treatment
Market Share Analysis, 2025, 2028, and 2033 (%)
Y-o-Y Growth Analysis, 2021 – 2033
Segment Trends
o Chronic Pain
Market Share Analysis, 2025, 2028, and 2033 (%)
Y-o-Y Growth Analysis, 2021 – 2033
Segment Trends
o Others
Market Share Analysis, 2025, 2028, and 2033 (%)
Y-o-Y Growth Analysis, 2021 – 2033
Segment Trends
6. Global Human Chorionic Gonadotropin (HCG) Market, By Distribution Channel, 2026-2033, (USD Bn)
o Introduction
Market Share Analysis, 2025, 2028, and 2033 (%)
Y-o-Y Growth Analysis, 2021 - 2033
Segment Trends
o Hospital Pharmacies
Market Share Analysis, 2025, 2028, and 2033 (%)
Y-o-Y Growth Analysis, 2021 – 2033
Segment Trends
o Retail Pharmacies
Market Share Analysis, 2025, 2028, and 2033 (%)
Y-o-Y Growth Analysis, 2021 – 2033
Segment Trends
o Online Pharmacies
Market Share Analysis, 2025, 2028, and 2033 (%)
Y-o-Y Growth Analysis, 2021 – 2033
Segment Trends
7. Global Human Chorionic Gonadotropin (HCG) Market, By Region, 2026-2033, (USD Bn)
o Introduction
Market Share Analysis, By Region, 2025, 2028, and 2033 (%)
Y-o-Y Growth Analysis, For Region, 2021 - 2033
o North America
Market Share Analysis, By Country, 2025, 2028 and 2033 (%)
Y-o-Y Growth Analysis, For Country, 2021 - 2033
Market Size and Forecast, By Product Type, 2026- 2033, (USD Bn)
Market Size and Forecast, By Therapeutic Application, 2026- 2033, (USD Bn)
Market Size and Forecast, By Distribution Channel, 2026- 2033, (USD Bn)
Market Size and Forecast, By Country, 2026- 2033, (USD Bn)
o U.S.
o Canada
o Latin America
Market Share Analysis, By Country, 2025, 2028 and 2033 (%)
Y-o-Y Growth Analysis, For Country, 2021 - 2033
Market Size and Forecast, By Product Type, 2026- 2033, (USD Bn)
Market Size and Forecast, By Therapeutic Application, 2026- 2033, (USD Bn)
Market Size and Forecast, By Distribution Channel, 2026- 2033, (USD Bn)
Market Size and Forecast, By Country, 2026- 2033, (USD Bn)
o Brazil
o Argentina
o Mexico
o Rest of Latin America
o Europe
Market Share Analysis, By Country, 2025, 2028 and 2033 (%)
Y-o-Y Growth Analysis, For Country, 2021 - 2033
Market Size and Forecast, By Product Type, 2026- 2033, (USD Bn)
Market Size and Forecast, By Therapeutic Application, 2026- 2033, (USD Bn)
Market Size and Forecast, By Distribution Channel, 2026- 2033, (USD Bn)
Market Size and Forecast, By Country, 2026- 2033, (USD Bn)
o U.K.
o Germany
o Italy
o France
o Spain
o Russia
o Rest of Europe
o Asia Pacific
Market Share Analysis, By Country, 2025, 2028 and 2033 (%)
Y-o-Y Growth Analysis, For Country, 2021 - 2033
Market Size and Forecast, By Product Type, 2026- 2033, (USD Bn)
Market Size and Forecast, By Therapeutic Application, 2026- 2033, (USD Bn)
Market Size and Forecast, By Distribution Channel, 2026- 2033, (USD Bn)
Market Size and Forecast, By Country, 2026- 2033, (USD Bn)
o China
o India
o Japan
o ASEAN
o Australia
o South Korea
o Rest of Asia Pacific
o Middle East
Market Share Analysis, By Country, 2025, 2028 and 2033 (%)
Y-o-Y Growth Analysis, For Country, 2021 - 2033
Market Size and Forecast, By Product Type, 2026- 2033, (USD Bn)
Market Size and Forecast, By Therapeutic Application, 2026- 2033, (USD Bn)
Market Size and Forecast, By Distribution Channel, 2026- 2033, (USD Bn)
Market Size and Forecast, By Country, 2026- 2033, (USD Bn)
o GCC Countries
o Israel
o Rest of Middle East
o Africa
Market Share Analysis, By Country/Region, 2025, 2028 and 2033 (%)
Y-o-Y Growth Analysis, For Country/Region, 2021 - 2033
Market Size and Forecast, By Product Type, 2026- 2033, (USD Bn)
Market Size and Forecast, By Therapeutic Application, 2026- 2033, (USD Bn)
Market Size and Forecast, By Distribution Channel, 2026- 2033, (USD Bn)
Market Size and Forecast, By Country, 2026- 2033, (USD Bn)
o South Africa
o North Africa
o Central Africa
8. Competitive Landscape
o Heat Map Analysis
o Market Share Analysis (3x3 Matrix)
o Company Profiles
Merck & Co., Inc.
o Company Overview
o Product Type Portfolio
o Recent Developments/Updates
Ferring B.V.,Fresenius SE & Co.KGaA
o Company Overview
o Product Type Portfolio
o Recent Developments/Updates
Lupin
o Company Overview
o Product Type Portfolio
o Recent Developments/Updates
Sun Pharmaceutical Industries Ltd.
o Company Overview
o Product Type Portfolio
o Recent Developments/Updates
Lee BioSolutions
o Company Overview
o Product Type Portfolio
o Recent Developments/Updates
Serum Institute of India Pvt. Ltd
o Company Overview
o Product Type Portfolio
o Recent Developments/Updates
Scripps Laboratories
o Company Overview
o Product Type Portfolio
o Recent Developments/Updates
Sanzyme Biologics Pvt. Ltd.
o Company Overview
o Product Type Portfolio
o Recent Developments/Updates
VHB Medi Sciences Limited Bharat Serums And Vaccines Limited (BSV)
o Company Overview
o Product Type Portfolio
o Recent Developments/Updates
Zydus Lifesciences Ltd
o Company Overview
o Product Type Portfolio
o Recent Developments/Updates
Corona Remedies Pvt. Ltd.
o Company Overview
o Product Type Portfolio
o Recent Developments/Updates
9. Analyst Recommendation
o Wheel of Fortune
o Analyst View
o Coherent Opportunity Map
10. Section
o References
o Research Methodology
o About Us and Sales Contact
提及公司
同分類最新報告（醫療與生命科學）
常見問題
這份報告可以先索取樣本嗎？
可以。建議購買前先申請樣本，提出申請後約 2 個工作天內提供，您可以先確認內容涵蓋範圍是否符合需求。
報告價格如何計算？
報告以美元標價，台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本（單人／多人／企業全站）價格不同，量子訊息會評估您的使用情境後提供最優惠報價。
下單後多久交付？如何付款？
一般 3–7 個工作天交付，實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票，30 天內電匯付款即可。
量子訊息有限公司為 Coherent Market Insights 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們